TERN 8-K 2026-01-09

Terns Pharmaceuticals, Inc. (TERN) 8-K dated 2026-01-09 — accession 0001193125-26-008907. This URL is the filing, not the TERN hub.

Terns Pharmaceuticals, Inc. (TERN) is a biotechnology company listed on NASDAQ.

Terns Pharmaceuticals, Inc. filed a 8-K on 2026-01-09. Accession 0001193125-26-008907.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.

Not investment advice. The TERN SEC hub lists recent forms. The stock page is the research view.